64 related articles for article (PubMed ID: 18945552)
1. Is prostate cancer an HPV-associated lesion?
Kong DB; Zheng XY; Xie LP; Sima N
Med Hypotheses; 2009 Jan; 72(1):101. PubMed ID: 18945552
[No Abstract] [Full Text] [Related]
2. Involvement of human papillomavirus infections in prostate cancer progression.
Al Moustafa AE
Med Hypotheses; 2008 Aug; 71(2):209-11. PubMed ID: 18468811
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer.
Santin AD; Bellone S; Gokden M; Cannon MJ; Parham GP
N Engl J Med; 2002 May; 346(22):1752-3. PubMed ID: 12037163
[No Abstract] [Full Text] [Related]
4. Primary and secondary prevention of cervical cancer--opportunities and challenges.
Markowitz LE; Unger ER; Saraiya M
J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
[No Abstract] [Full Text] [Related]
5. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
[TBL] [Abstract][Full Text] [Related]
6. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
7. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions.
Coutlée F; Trottier H; Gagnon S; Koushik A; Richardson H; Roger M; Ferenczy AS; Franco EL
J Clin Virol; 2009 Jun; 45(2):96-9. PubMed ID: 19398216
[TBL] [Abstract][Full Text] [Related]
8. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
Matovina M; Sabol I; Grubisić G; Gasperov NM; Grce M
Gynecol Oncol; 2009 Apr; 113(1):120-7. PubMed ID: 19157528
[TBL] [Abstract][Full Text] [Related]
9. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
[TBL] [Abstract][Full Text] [Related]
10. Re: Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
Cai T; Mazzoli S; Bartoletti R
J Natl Cancer Inst; 2008 Apr; 100(8):600; author reply 600-1. PubMed ID: 18398096
[No Abstract] [Full Text] [Related]
11. Sex and prostate cancer: a new risk factor?
Harv Mens Health Watch; 2002 Jan; 6(6):7-8. PubMed ID: 11823170
[No Abstract] [Full Text] [Related]
12. Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy.
Broccolo F; Chiari S; Piana A; Castiglia P; Dell'Anna T; Garcia-Parra R; Maneo A; Villa A; Leone EB; Perego P; Maida A; Mangioni C; Cocuzza CE
J Med Virol; 2009 Feb; 81(2):278-87. PubMed ID: 19107971
[TBL] [Abstract][Full Text] [Related]
13. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Yugawa T; Kiyono T
Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
[TBL] [Abstract][Full Text] [Related]
15. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
16. Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer.
Hsu NY; Cheng YW; Chan IP; Ho HC; Chen CY; Hsu CP; Lin MH; Chou MC
Oncol Rep; 2009 Jan; 21(1):81-7. PubMed ID: 19082446
[TBL] [Abstract][Full Text] [Related]
17. Cervical carcinoma in Southern Mexico: Human papillomavirus and cofactors.
Illades-Aguiar B; Cortés-Malagón EM; Antonio-Véjar V; Zamudio-López N; Alarcón-Romero Ldel C; Fernández-Tilapa G; Hernández-Sotelo D; Terán-Porcayo MA; Flores-Alfaro E; Leyva-Vázquez MA
Cancer Detect Prev; 2009; 32(4):300-7. PubMed ID: 19022588
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion.
Cricca M; Venturoli S; Leo E; Costa S; Musiani M; Zerbini M
J Med Virol; 2009 Jul; 81(7):1276-82. PubMed ID: 19475620
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer screening in the early post vaccine era.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Human Papilloma Virus (HPV) in Cervical Mucosa.
Chauhan SC; Jaggi M; Bell MC; Verma M; Kumar D
Methods Mol Biol; 2009; 471():439-56. PubMed ID: 19109793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]